Research is being conducted to better understand the complexity of endometrial cancer and its response to various therapies. Studies are utilizing single-cell analysis to dissect molecular heterogeneity in different types of cancer, including endometrial cancer and metastatic melanoma. The investigations appear to be exploring various signaling pathways and potential therapeutic targets, such as the inhibition of lanosterol synthase.